Skip to main content

Yolanda Villena Ortiz

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Yolanda Villena Ortiz

Yolanda Villena Ortiz

Yolanda Villena Ortiz

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Estudio de validación de una aplicación para Smartphone (NORA) en pacientes con enfermedad renal diabética avanzada. Efecto en la progresión de la enfermedad renal y la mortalidad cardiovascular en época COVID.

IP: Maria Jose Soler Romeo
Collaborators: Yolanda Villena Ortiz, Joan López Hellin
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 24000
Reference: SENEFRO/PROJECTES/2021/SOLER
Duration: 15/07/2021 - 14/01/2023

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Luisa Maria Martinez Sánchez

Luisa Maria Martinez Sánchez

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Francisco Javier  Ramos  Gómez

Francisco Javier Ramos Gómez

Shock, Organ Dysfunction and Resuscitation
Read more
Daniel Carranza Rojo

Daniel Carranza Rojo

Senior researcher
Pediatric Neurology
Read more
Maira Cortes Espriu

Maira Cortes Espriu

Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.